Correction: Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort

PDF  |  How to cite

Oncotarget. 2020; 11:758-758. https://doi.org/10.18632/oncotarget.27480

Metrics: PDF 1305 views  |   ?  

Tomi Akinyemiju1, Justin X. Moore2, Daniel T. Dibaba3, Maria Pisu4, Michael Goodman5, Virginia J. Howard6, Monika Safford7, Susan C. Gilchrist8, Mary Cushman9, LeAnn Long10 and Suzanne E. Judd10

1 Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA
2 Division of Public Health Sciences and Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA
3 Tennessee Clinical and Translational Science Institute, University of Tennessee Health Science Center, Memphis, TN, USA
4 Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham AL, USA
5 Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA
6 Department of Epidemiology, University of Alabama at Birmingham, Birmingham AL, USA
7 Department of Medicine, Weill Cornell Medical College, New York, NY, USA
8 Department of Clinical Cancer Prevention and Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
9 Department of Medicine and Vermont Cancer Center, Larner College of Medicine at the University of Vermont, Burlington, VT, USA
10 Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA

Published: February 18, 2020

This article has been corrected: The third author in the listing, along with a new affiliation, has been added as follows:

Daniel Tefera Dibaba3

Original article: Oncotarget. 2019; 10:4857–4867. DOI: https://doi.org/10.18632/oncotarget.27108.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27480